Hana Línková

Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study

Jonathan P. Piccini, Valeria Caso, Stuart J. Connolly et al. · The Lancet · 2022 · 296 citations · Full text

Thrombosis, Dose-finding Phase 2, Cardiovascular Disease +10

Predictors of Improvement of Unrepaired Moderate Ischemic Mitral Regurgitation in Patients Undergoing Elective Isolated Coronary Artery Bypass Graft Surgery

Martin Pěnička, Hana Línková, Otto Lang et al. · Circulation · 2009 · 142 citations

A pilot randomised trial of catheter-directed thrombolysis or standard anticoagulation for patients with intermediate-high risk acute pulmonary embolism

J Kroupa, Michal Buk, J. Weichet et al. · EuroIntervention · 2022 · 46 citations

Changes and Prognostic Impact of Apoptotic and Inflammatory Cytokines in Patients Treated with Cardiac Resynchronization Therapy

Pavel Osmančík, Dalibor Heřman, Petr Štros et al. · Cardiology · 2013 · 35 citations

Bipolar anodal septal pacing with direct LBB capture preserves physiological ventricular activation better than unipolar left bundle branch pacing

Karol Čurila, Pavel Jurák, Frits W. Prinzen et al. · Frontiers in Cardiovascular Medicine · 2023 · 21 citations · Full text